<DOC>
	<DOCNO>NCT00515879</DOCNO>
	<brief_summary>This study assess effectiveness D-cycloserine combine cognitive-behavior therapy treat people social anxiety disorder .</brief_summary>
	<brief_title>Effect D-cycloserine Plus Cognitive Behavioral Therapy People With Social Phobia</brief_title>
	<detailed_description>Social anxiety disorder ( SAD ) among common psychiatric condition associate significant distress dysfunction social situation . Although treatment cognitive-behavior therapy ( CBT ) know help remedy SAD , many patient respond treatment reach full recovery . In CBT , patient undergo repeat prolonged exposure practice fear social situation learn good way deal anxiety setting . Exposure therapy base animal model extinction condition fear , recent animal research identify core pathway neurotransmitter involve fear extinction . D-cycloserine ( DCS ) drug appear facilitate learn process extinction condition fear animal human . This study ass effectiveness DCS combine CBT treat people SAD . Participants double-blind study randomly assign active control group . All participant attend 18 study visit Center Anxiety Related Disorders 9-month period . There 12 CBT session 90 minute 6 assessment visit . The CBT session help participant become comfortable social situation . During 5 CBT session , participant receive pill contain either DCS sugar ( placebo ) . Assessment visit include interview , self-report questionnaire , laboratory test . These visit occur Weeks 1 , 7 , 12 treatment Months 3 , 6 , 9 post-treatment .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Meets DSMIV criterion generalize social anxiety disorder ( GSAD ) Total score great equal 60 LSAS Physical examination , electrocardiogram , laboratory finding without clinically significant abnormality Lifetime history bipolar disorder , schizophrenia , psychosis , delusional disorder , obsessivecompulsive disorder Eating disorder within 6 month prior study entry History organic brain syndrome , mental retardation , cognitive dysfunction Substance alcohol abuse dependence ( nicotine ) within 6 month prior study entry inability refrain alcohol use acute period study participation Posttraumatic stress disorder within 6 month prior study entry ; entry patient mood anxiety disorder permit social anxiety disorder judge predominant disorder Suicidal thought Taking concurrent psychotropic medication ( e.g. , antidepressant , anxiolytic , beta blocker ) within 2 week study entry Significant personality dysfunction Serious medical illness instability hospitalization may likely within next year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Generalized subtype</keyword>
</DOC>